IPCA Laboratories share news, announcements and annual reports
NSE: IPCALABBSE: 524494Pharmaceuticals & BiotechnologyMid Cap
IPCA Laboratories Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994 on BSE, Feb 1995 on NSE
Last close ₹1,926.20down ₹4.30 (0.22%)BSE ₹1,925.85
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,930.50.
29 Oct: open ₹1,910.50, high ₹1,978.00, low ₹1,910.50
52-week range of traded prices to 29 Oct 2026
₹1,268.00Low, 31 Oct 2025₹2,038.00High, 18 Sep 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹48,869 Cr229th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 37.31
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.06
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.31%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 17.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,90,81052.2% delivered
IPCA Laboratories orders, deals and press releases
63 filed, newest first. Page 2 of 2.
May 2010
Jan 2010
21 Jan · Business
Ipca Laboratories Ltd. has informed the Exchange regarding a press release dated January 21, 2010, titled "Ipca Laboratories Q3 FY10 Results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
27 Oct · Business
Ipca Laboratories Ltd. has informed the Exchange regarding a press release dated October 27, 2009, titled "Ipca Laboratories Q2 FY10 Results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
30 Jul · Business
Ipca Laboratories Ltd. has informed the Exchange regarding a press release dated July 30, 2009, titled "Ipca Laboratories Q1 FY10 Results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
28 May · Business
Ipca Laboratories Ltd. has informed the Exchange regarding a press release dated May 28, 2009 titled "Ipca- Financial Results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
22 Jan · Business
Ipca Laboratories Ltd. has informed the Exchange regarding a press release titled "Ipca- Financial Result". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
31 Oct · Business
Ipca Laboratories Ltd. has informed the Exchange regarding a press release titled "Ipca- Financial Result". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Oct · Business
Ipca Laboratories Ltd. has informed the Exchange regarding a press release dated October 13, 2008, titled "IPCA-Heritage Alliance Introduces Propranolol Tablets in the U.S.Market". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
25 Jul · Business
Ipca Laboratories Ltd. has informed the Exchange regarding a press release dated July 25, 2008, titled "Q1 Financial Results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2008
29 May · Business
Ipca Laboratories Ltd. has informed the Exchange regarding a press release dated May 29, 2008, titled "Ipca- Financial Result". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2007
13 Sep · Business
Ipca Laboratories Ltd. has informed the Exchange that "The Company has acquired 100% shareholding of a small formulation product dossier registration-cum-distribution company in Australia. This company is currently holding 5 formulation registration dossiers in that country. This Australian company is also having a wholly owned formulation dossier registration-Cum-distribution company in New Zealand currently holding 3 formulation registration dossiers in New Zealand. Acquisition of these companies will help Ipca in strengthening its existing formulations business in Australia and New Zealand".
Aug 2007
27 Aug · Business
Ipca Laboratories Ltd. has informed the Exchange that Central Drug Research Institute (CDRI) has entered into a collaborative-cum-license agreement with Ipca for further development of its compound 99/411, a promising synthetic substitute for drugs based on Artemisinin derived from the plant Artemisia annua. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2007
25 May · Business
Ipca Laboratories Ltd. has informed the Exchange regarding a press release dated May 25, 2007, with respect to the Board Meeting held on May 25, 2007 for the Audited Financial Results of the Company for the financial year ended March 31, 2007. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.